Delivery Order SPE2DB22D3009-SPE2DB23FAQ02
- Not listed
- This federal contract award, with ID SPE2DB20D3104|SPE2DB23FV6Q2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,071.18 firm fixed-price delivery order is for the supply of 4560862553 - RIZATRIPTAN 5 MG TABLET UD 18S. The contract has an ultimate completion date of May 9, 2023 and was awarded on May 8, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a...
- This federal contract award, valued at $2,629.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4560665789 RIZATRIPTAN 10 MG TABLET UD 18S, and has an ultimate completion date of April 21, 2023. The contract is a firm fixed-price agreement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,104.12 firm fixed-price delivery order is for the supply of RIZATRIPTAN 10 MG TABLET UD 18S, with a performance period through February 14, 2025. The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,980.91, is for the delivery of RIZATRIPTAN 10 MG ODT UD 3S, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 10, 2023. The contract was not designated with a set-aside. AmerisourceBergen holds a...
- This federal contract award, SPE2DB22D1106|SPE2DB24FEZJ1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,967.40 Firm Fixed Price delivery order is for the supply of 4565020822 ! RIZATRIPTAN 10 MG ODT UD 18S, a pharmaceutical product. The contract has an ultimate completion date of June 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of RIZATRIPTAN 10 MG ODT UD 3S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price type, valued at $95,673.52, and has an ultimate completion date of October 13, 2023. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,876.29 Delivery Order covers the supply of 4563282943 ! RIZATRIPTAN 5 MG ODT UD 3S, a prescription medication, with a period of performance ending on January 10, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This federal contract award, valued at $5,831.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIZATRIPTAN 10 MG ODT UD 3S, a pharmaceutical product, with a completion date of May 5, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order, valued at $1,313.42, is for the supply of RIZATRIPTAN 5 MG ODT UD 18S, a pharmaceutical product. The contract is a firm-fixed-price delivery order with a completion date of September 18, 2024. This order is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds numerous federal contracts,...
- This federal contract award, with an ID of SPE2DB22D3016|SPE2DB23FBAW4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560840792 ! RIZATRIPTAN 10 MG ODT UD 3S, with a ceiling value of $8,138.87 and a completion date of May 8, 2023. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB23FAQ02Delivery Order
This federal contract award, with ID SPE2DB22D3009|SPE2DB23FAQ02, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract, valued at $1,335.83, is for the delivery of 4560716745 - RIZATRIPTAN 5 MG TABLET UD 18S. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 26, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/25/23 |